Joshua A Kritzer, PhD

Job title:
NRSA Postdoctoral Fellow
Organization:
Whitehead Institute for Biomedical Research
Contributions:
Published Contributions:
Q&A with Dr. Joshua Kritzer - a novel yeast-based drug discovery strategy
Targeting Alpha-Synuclein
13 Jul 2009 01:03 PM EST
Dr. Joshua Kritzer, a postdoctoral fellow with Dr. Susan Lindquist at the Whitehead Institute, discusses his new publication in Nature Chemical Biology with Dr. Michael Rogan of MJFF. Dr. Kritzer ... 
Responses: 2
Response by the Author re: Kritzer et al. 2009
Targeting Alpha-Synuclein
17 Jul 2009 03:44 PM EST
I appreciate Dr. Wolozin's enthusiasm for this technology -- we, too, hope that it will find great use both for diseases of poorly understood etiology such as PD as well as for other drug discovery ...